ErbB/BTK inhibitors

• 收藏
• 分享

专利权人:

Dizal (Jiangsu) Pharmaceutical Co.; Ltd

发明人:

LI, Zhengtao,ZOU, Hao,ZHU, Wei,SHEN, Changmao,WANG, Rumin,LIU, Wengeng,CHEN, Xiang,TSUI, Honchung,YANG, Zhenfan,ZHANG, Xiaolin

申请号：

AU2019215538

公开号：

AU2019215538A1

申请日:

2019.01.28

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Disclosed are compounds inhibiting ErbBs (e. g., EGFR or Her 2), especially mutant forms of ErbBs, and BTK, pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compound and the pharmaceutical composition can effectively treat ErbBs (especially mutant forms of ErbBs) or BTK associated diseases, including cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/